Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation.

Wei-Chen LeeHong-Shiue ChouTsung-Han WuChih-Hsien ChengChen-Fang LeeYu-Chao WangTing-Jung WuKun-Ming Chan

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

Perioperative low-dose HBIg and antiviral nucleotide/nucleoside can effectively prevent HBV recurrence in patients with slow HBIg decline. For patients with quick HBIg decline, the idealized HBIg and antiviral agent regimen should be adjusted to establish an effective regimen as prophylaxis against HBV recurrence.

Keyphrases

low dose
hepatitis b virus
free survival
high dose
liver failure
cardiac surgery
patients undergoing